Table 5.
Antibacterial activity of Bi(III) carboxylate complexes against Helicobacter pylori strain 26695.
| Compound | Representation of Bi(III) Coordination | Chromophore | MIC µg mL−1 (µM) | Ref. |
|---|---|---|---|---|
| Pyridinedicarboxylic acid | ||||
| [Bi2(2,3pydc)2(2,3pydcH)2(H2O)]n (1) |
|
{BiO7N2} | 15.0 (13.7) | This work |
| {(Et3NH)2[Bi(2,3pydc)(2,3pydcH)Cl2]}n (2) |
|
{BiO4N2Cl2} | 30.0 (36.8) | |
| BSS | 12.5 (34.5) | |||
| Indolecarboxylic acid | ||||
| [Bi(IAA)3] |
 [Bi(IAA)3] |
{BiO6} | 6.25 (8.54) | [67] |
| [Bi(IPA)3] | {BiO6} | 6.25 (8.07) | ||
| [Bi(IBA)3] | {BiO6} | 6.25 (7.66) | ||
| [Bi(MICA)3] | {BiO6} | 6.25 (8.54) | ||
| [Bi(IGA)3] | {BiO6} | 6.25 (8.08) | ||
| BSS | 12.5 (34.5) | |||
| Acetylsalicylic acid | ||||
| [Bi(asp)3]∞ |
 [Bi(asp)3]∞ |
{BiO8} | 6.25 (8.37) | [70] |
| [KBi(asp)4]∞ | {BiO9} | 6.25 (6.48) | ||
| NSAIDs | ||||
| [Bi(L1)3·H2O] |
 [Bi(Ketoprofen)3·H2O] |
{BiO6} | ≥6.25 (6.35) | [68] |
| ≥6.25 (4.85) | ||||
| [Bi(L2)3] | {BiO6} | ≥6.25 (7.01) | ||
| ≥6.25 (7.58) | ||||
| ≥6.25 (6.47) | ||||
| ≥6.25 (8.67) | ||||
| ≥6.25 (6.75) | ||||
| ≥6.25 (6.55) | ||||
| ≥6.25 (6.33) | ||||
| ≥6.25 (5.97) | ||||
| BSS | ≥12.5 (34.5) | |||
2,3pydcH2—pyridine-2,3-dicarboxylic acid; Et3N—triethylamine; BSS—bismuth subsalicylate; IAA-H—2-(1H-indol-3-yl)acetic acid, IPA-H—3-(1H-indol-3-yl)propanoic acid, IBA-H—4-(1H-indol-3-yl))butanoic acid, IGA-H—2-(1H-indol-3-yl))-2-oxoacetic acid, MICA-H—1-methyl-1H-indole-3-carboxylic acid; aspH—acetylsalicylic acid; NSAIDs: L1: Ketoprofen, Sulindac; L2: Naproxen, Ibuprofen, Fenbufen, 5-Chlorosalicylic acid, Mefenamic acid, Diflunisal, Tolfenamic acid, Flufenamic acid.